Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Shares Outstanding (2017 - 2025)

Puma Biotechnology's Shares Outstanding history spans 9 years, with the latest figure at $50.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 2.65% year-over-year to $50.4 million; the TTM value through Dec 2025 reached $50.4 million, up 2.65%, while the annual FY2025 figure was $50.4 million, 2.65% up from the prior year.
  • Shares Outstanding reached $50.4 million in Q4 2025 per PBYI's latest filing, roughly flat from $50.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $50.4 million in Q4 2025 to a low of $40.3 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $46.5 million, with a median of $47.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: grew 2.56% in 2021, then increased 12.56% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $41.2 million in 2021, then grew by 12.56% to $46.3 million in 2022, then increased by 2.81% to $47.6 million in 2023, then rose by 3.06% to $49.1 million in 2024, then rose by 2.65% to $50.4 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Shares Outstanding are $50.4 million (Q4 2025), $50.4 million (Q3 2025), and $49.9 million (Q2 2025).